Phathom Seeks Approval of Vonoprazan-Based Regimens for H. Pylori Infection
The applications are based on data from the phase 3 PHALCON-HP trial.
H Pylori Infection
Eradication Therapy for Treatment of Helicobacter Pylori Infection Linked to Altered Gut Microbiota, Ghrelin Concentrations
Investigators conducted a study to determine the relationship between gut microbiota and ghrelin concentrations among patients with positive Helicobacter pylori infection vs those with antigen-negative H pylori infection who received eradication therapy.
Resistant Strains of Helicobacter pylori Across Europe Associated With Historical Antibiotic Use
Investigators assessed the link between antibiotic consumption and resistance and H pylori infections in European countries.
Vonoprazan-Based Triple Therapy: Most Effective Worldwide for Helicobacter pylori
Researchers performed a network meta-analysis to compare the effectiveness of first-line regimens vs standard triple therapy in the treatment of H pylori infection.
High-Dose Dual Therapy vs Bismuth Quadruple Therapy for Helicobacter pylori Eradication
Researchers compared the efficacy, adverse events, and compliance of HDDT vs BQT as first-line or rescue regimens and investigated factors contributing to H pylori eradication.
Helicobacter pylori Eradication Failure More Frequent Among Patients With HIV Coinfections
Researchers aimed to evaluate outcomes of H pylori treatment and identify any risk factors for failure in patients with HIV.
Study Shows Vonoprazan-Based Regimens Noninferior to PPI-Based Triple Therapy
Vonoprazan is an oral small molecule potassium-competitive acid blocker.
Abdominal Pain, Diarrhea in COVID-19 Linked to H pylori Infection
Researchers investigated the effects of H pylori on the clinical presentation and disease course of COVID-19 infections.
Trends and Predictions in Gastric Cancer Incident Rates from a Global Perspective
Investigators sought to explore the past temporal trends (1988-2012) in gastric cancer incidence rates in 43 countries and to predict future trends (2012-2030).
EndoFaster® Device May Be Effective for Real-Time H pylori Detection
Investigators tested the accuracy of the EndoFaster® device in performing gastric juice analysis, with the goal of reducing the need for gastric biopsies in the detection of H pylori.
- Loading...
Loading...
Next post in H pylori infection
Loading... 
Loading...